Intervention
Telmisartan/Amlodipine
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
3 shownEfficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With HyperlipidemiaNCT03566316 · 2015-11-24
COMPLETEDEfficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension PatientsNCT02738632 · 2015-05-01
COMPLETEDThe Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/AmlodipineNCT02387619 · 2015-02-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED3
Phase mix
PHASE32
PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.